feed,title,long_url,short_url
Benzinga,InflaRx's Vilobelimab Shows Encouraging Signs Of Drug Activity In Mid-Stage Study With Dermatological Ulcer Patients,https://benzinga.com/general/biotech/21/08/22420520/inflarxs-vilobelimab-shows-encouraging-signs-of-drug-activity-in-mid-stage-study-with-dermatologi,https://j.mp/3Ax0cN4
